IN
Indo Borax & Chemicals Ltd (INDOBORAX)
₹359.50
Mkt cap
₹1,215 Cr
P/E ratio
28.60
P/B
4.02
Div yield
2.64%
ROE
10.10%
ROCE
15.40%
EPS (TTM)
₹12.57
Book value
₹89
52W range
230–543
Sector
Commodities
Price history
Previous close
Incorporated in 1980, Indo Borax & Chemicals Ltd is in the business of manufacturing Boron and Lithium products [1]
NSE INDOBORAXBSE 524342
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsNeutral
52-week range
−33.77% from high₹360
₹230+56.00% from low₹543
Current
₹359.50
Prev close
₹370.85
Day
−3.06%
Price performance
1D
−2.91%
1W
−4.92%
1M
−15.24%
3M
−27.72%
6M
+11.01%
1Y
+37.48%
YTD
+34.04%
Financials
Revenue, profit & margin
P/E ratio
28.6×
INDOBORAX is 53% above the sector median of 18.7×
INDOBORAX28.6×
Sector median18.7×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 46.80 | 44.06 | 45.46 | 49.76 | 37.87 | 37.51 | 50.12 | 53.57 | 57.85 | 41.02 | 63.01 | 70.36 | 58.94 | |
| YoY Sales growth | -23.59% | -20.41% | -18.73% | -9.49% | -19.08% | -14.87% | +10.25% | +7.66% | +52.76% | +9.36% | +25.72% | +31.34% | +1.88% | |
| Expenses | 36.64 | 34.88 | 33.89 | 33.31 | 28.71 | 27.44 | 39.92 | 41.36 | 47.35 | 32.40 | 50.19 | 50.56 | 57.46 | |
| Operating Profit | 10.16 | 9.18 | 11.57 | 16.45 | 9.16 | 10.07 | 10.20 | 12.21 | 10.50 | 8.62 | 12.82 | 19.80 | 1.48 | |
| OPM % | 21.71% | 20.84% | 25.45% | 33.06% | 24.19% | 26.85% | 20.35% | 22.79% | 18.15% | 21.01% | 20.35% | 28.14% | 2.51% | |
| Other Income | 2.69 | 2.74 | 3.36 | 3.25 | 4.35 | 4.24 | 3.75 | 3.02 | 12.92 | 4.33 | 5.32 | 2.56 | 7.89 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.17 | 0.00 | 0.00 | 0.00 | 0.06 | 0.05 | 1.13 | |
| Depreciation | 0.57 | 0.57 | 0.59 | 0.50 | 0.52 | 0.62 | 1.00 | 0.86 | 0.86 | 0.81 | 0.63 | 0.31 | 0.46 | |
| Profit before tax | 12.28 | 11.35 | 14.34 | 19.20 | 12.99 | 13.69 | 12.78 | 14.37 | 22.56 | 12.14 | 17.45 | 22.00 | 7.78 | |
| Tax % | 27.36% | 27.49% | 20.22% | 27.03% | 29.25% | 33.75% | 19.87% | 29.02% | 27.88% | 23.72% | 16.68% | 26.09% | 39.20% | |
| Net Profit | 8.93 | 8.23 | 11.44 | 14.01 | 9.18 | 9.07 | 10.24 | 10.20 | 16.26 | 9.27 | 14.53 | 16.25 | 4.74 | |
| EPS in Rs | 2.78 | 2.56 | 3.56 | 4.37 | 2.86 | 2.83 | 3.19 | 3.18 | 5.07 | 2.89 | 4.53 | 5.06 | 1.48 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202638.41%Promoter
Promoters38.41%
FIIs0.10%0.03
DIIs0.04%
Public61.45%0.02
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| SRF | ₹2,475.00 | 31.06 | 73,365 | 0.36% | 509 | +31.16% | 4,904 | +34.72% | 14.61% |
| Deepak Fertilis. | ₹1,261.80 | 13.68 | 15,929 | 0.79% | 394 | +84.69% | 3,334 | +10.92% | 11.42% |
| Tata Chemicals | ₹605.90 | — | 15,436 | 1.82% | −50 | −224.22% | 4,177 | +7.74% | 3.42% |
| Tanfac Inds. | ₹3,349.40 | 104.27 | 7,246 | 0.13% | 19 | +10.77% | 230 | +36.63% | 23.90% |
| G N F C | ₹469.60 | 6.56 | 6,900 | 4.47% | 194 | +8.38% | 2,773 | +40.90% | 12.03% |
| Gujarat Alkalies | ₹590.45 | 32.71 | 4,336 | 3.00% | 83 | +405.32% | 1,358 | +25.32% | 1.42% |
| GHCL | ₹445.40 | 8.12 | 4,104 | 2.69% | 127 | +18.68% | 808 | +12.03% | 17.60% |
| Indo Borax & Ch. | ₹378.70 | 28.62 | 1,215 | 2.64% | 5 | −68.21% | 59 | +1.88% | 15.37% |
| Median: 44 Co. | ₹165.97 | 18.66 | 690 | 0.34% | 7 | +13.08% | 126 | +25.00% | 10.30% |
Filings
Annual reports15
Concall transcripts6
Credit ratings2
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 12 NovAnnouncement under Regulation 30 (LODR)-Press Release / Media Release 11 Nov - H1FY27 operating income rose 16% to Rs 129.29 crore; completed 64.26% Kronox acquisition and named Suresh Kalra MD/CEO.Announcement under Regulation 30 (LODR)-Newspaper Publication 9 Nov - Copies of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended 30th September, 2026 published in Free Press Journal and NavshaktiUnaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2026. 6 Nov - Board approved Q2 FY27 results; acquired 64.26% of Kronox Lab Sciences on 29 Sep 2026.Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. November 06, 2026. 6 Nov - Board approved Q2 FY27 results and reported 64.26% Kronox Lab Sciences acquisition on 29 Sep 2026.





